6. Glycemic Targets: Standards of Care in Diabetes—2023

Cited by (721)

Items 201–300 of 721

  1. Clinical perspectives on the frequency of hypoglycemia in treat-to-target randomized controlled trials comparing basal insulin analogs in type 2 diabetes: a narrative review
    Julio Rosenstock, HARPREET SINGH BAJAJ, Ildiko Lingvay, Simon R. Heller · 2024 · BMJ Open Diabetes Research & Care
  2. Postprandial glycemic response to a high-protein diabetes-specific nutritional shake compared to isocaloric instant oatmeal in people with type 2 diabetes: a randomized, controlled, crossover trial
    Sara Thomas, Beth Y. Besecker, Yong S Choe, Elena Christofides · 2024 · Frontiers in Clinical Diabetes and Healthcare
  3. DiaBetter Together: Clinical trial protocol for a strengths-based Peer Mentor intervention for young adults with type 1 diabetes transitioning to adult care
    Samantha A Carreon, Charles Gene Minard, Sarah K. Lyons, Wendy L. Levy, Stephanie Camey, Kishan Desai, Brenda Duran, Randi M. Streisand, Barbara J. Anderson, Siripoom Vudhipoom McKay et al. · 2024 · Contemporary Clinical Trials
  4. Elevated Triglyceride-Glucose Index as a Risk Stratification Marker for Diabetic Retinopathy in Type 2 Diabetes Mellitus: The Influence of Glycemic Control
    Xiaohua Wan, Ruihuan Zhang, Adilan Abudukeranmu, Wei Wei, Hong Zhu, Lin Zhang, Yan‐Wei Hu · 2025 · Diabetes Metabolic Syndrome and Obesity
  5. Improved Glycaemic and Weight Management Are Associated with Better Quality of Life in People with Type 2 Diabetes Treated with Tirzepatide
    Kristina Secnik Boye, Hélène Sapin, Wenxiu Dong, SUZANNE E. WILLIAMSON, Clare J. Lee, Vivian Thuyanh Thieu · 2023 · Diabetes Therapy
  6. Diabetes-related complications, glycemic levels, and healthcare utilization outcomes after therapeutic inertia in type 2 diabetes mellitus
    Cassidi C. McDaniel, Wei‐Hsuan Lo‐Ciganic, Chiahung Chou · 2024 · Primary care diabetes
  7. Haptoglobin Phenotype and Intensive Glycemic Control for Coronary Artery Disease Risk Reduction in People With Type 2 Diabetes: The ADVANCE Study
    Leah E. Cahill, Rachel A. Warren, Allie S. Carew, Andrew P. Levy, John L. Sapp, Michelle Samuel, Elizabeth Selvin, Samantha K. Lavallée, Neil R Poulter, Michel Marre et al. · 2024 · Diabetes Care
  8. Discrepancy in diagnoses of diabetes and prediabetes using fasting plasma glucose and glycosylated hemoglobin and the underdiagnosis by ICD-10 coding: data from a tertiary hospital in Thailand
    Napalai Poorirerngpoom, Poranee Ganokroj, Arnond Vorayingyong, Thanapoom Rattananupong, Jennifer Pusavat, Thanan Supasiri · 2023 · Frontiers in Public Health
  9. The relationship between repeated measurements of HbA1c and risk of coronary events among the common haptoglobin phenotype groups: the Action for Health in Diabetes (Look AHEAD) study
    Allie S. Carew, R. A. Warren, Michael P. Bancks, Mark Andrew Espeland, Judy L. Bahnson, Cora Elizabeth Lewis, Andrew P. Levy, John L. Sapp, Robin Urquhart, J. L. Wang et al. · 2024 · Cardiovascular Diabetology
  10. GlyMan: Glycemic Management using Patient-Centric Counterfactuals
    Asiful Arefeen, Saman Khamesian, Adela Grando, Bithika Thompson, Hassan G Ghasemzadeh · 2024 · IEEE-EMBS International Conference on Biomedical and Health Informatics (BHI ...)
  11. Hybrid Closed Loop in Adolescents and Young Adults Living with Type 1 Diabetes: A Real-World Study
    Marine Ung, Alfred Penfornis, Clarisse Valentim, Sylvia Franc, Coralie Amadou, Juliette Eroukhmanoff · 2025 · Diabetes Technology & Therapeutics
  12. The Liver Disease-Related Hypoglycemia: An Overview of the Impact, Management Approaches, and Underlying Mechanisms
    Lixiao Shen, Yin-gui Wu, Ke Ming · 2025 · British Journal of Hospital Medicine
  13. Real-World Effectiveness of Tirzepatide versus Semaglutide on HbA1c and Weight in Patients with Type 2 Diabetes
    Meredith M. Hoog, Carlos R. Vallarino, Juan M. Maldonado, Michael Grabner, Chia‐Chen Teng, Kendra A. Terrell, Emma L. Richard · 2025 · Diabetes Therapy
  14. Prevalence of periodontitis and oral hygiene practices among diabetic and non-diabetic patients in a tertiary hospital in Lagos: a cross-sectional study
    Kehinde Olubukola Ojo, Oluwakemi Ololade Odukoya, Patricia Omowunmi Ayanbadejo, Damilola O. Akinlawon · 2023 · Pan African Medical Journal
  15. Influence of the duration of type 2 diabetes mellitus on colorectal cancer outcomes
    Magdolna Herold, Attila Marcell Szász, Gyöngyvér Szentmártoni, Emoke Martinek, Viktor Madar-Dank, Andras Jozsef Barna, Réka Mohácsi, Anikó Somogyi, Magdolna Dank, Zoltán Herold · 2023 · Scientific Reports
  16. Factors associated with therapeutic inertia in individuals with type 2 diabetes mellitus started on basal insulin
    Sharmin Shabnam, Clare Gillies, Melanie Jane Davies, TERRY A. DEX, Eka Melson, Kamlesh Khunti, David R. Webb, Francesco Zaccardi, Samuel Seidu · 2023 · Diabetes Research and Clinical Practice
  17. Safety and performance of a hybrid closed-loop insulin delivery system with carbohydrate suggestion in adults with type 1 diabetes prone to hypoglycemia
    Alex Mesa, Aleix Beneyto, Juan José, Judith Viaplana, Jorge Bondía, Josep Vehı́, Ignacio Conget, Marga Giménez · 2023 · Diabetes Research and Clinical Practice
  18. Mandatory monthly outpatient visits could improve therapeutic inertia in patients with poorly controlled type 2 diabetes
    Ying-Ying Tsai, Ting‐Yu Kuo, Meng‐Hung Lin, Feng‐Chih Shen, Yung‐Hsiang Lin · 2023 · Journal of Diabetes Investigation
  19. An Economic Evaluation of the Relationship Between Glycemic Control and Total Healthcare Costs for Adults with Type 2 Diabetes: Retrospective Cohort Study
    Kristina Secnik Boye, Jay Patrick Bae, Vivian Thuyanh Thieu, Maureen J. Lage · 2023 · Diabetes Therapy
  20. Maintaining an active lifestyle from adolescence to adulthood might alleviate the adverse association of preterm birth with cardiometabolic health
    Yasmín Ezzatvar, José Francisco López‐Gil, Míkel Izquierdo, Antônio García‐Hermoso · 2024 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
  21. The Impact of Disease Duration on Microcirculatory Dysfunction in Young Patients with Uncomplicated Type 1 Diabetes
    Jolanta Neubauer‐Geryk, Melanie Wielicka, Magdalena Hoffmann, Małgorzata Myśliwiec, Leszek Bieniaszewski · 2024 · Biomedicines
  22. Exploring the Impact of Device Sourcing on Real-World Adherence and Cost Implications of Continuous Glucose Monitoring in Patients With Diabetes: Retrospective Claims Analysis
    Jason C. Allaire, Consuela Dennis, Arti Masturzo, Steven D. Wittlin · 2024 · JMIR Diabetes
  23. Real-world evaluation of vascular complications and comorbidities in Portuguese patients with type 2 diabetes: Results from the cMORE study
    Sílvia Alão, Tomás Silva, António Pedro Leite, Medina do Rosário, Cristina Carvalho, Joana Coelho, Hélder José Ferreira, Raquel Ferreira, Joana Abreu, Margarida Rosa et al. · 2024 · Revista Portuguesa de Cardiologia
  24. Cluster analysis of adult individuals with type 1 diabetes: Treatment pathways and complications over a five-year follow-up period
    Francisco Javier Somolinos-Simón, Gema García-Sáez, José Antonio Rivera Tapia, Rosa Corcoy, M. Elena Hernando · 2024 · Diabetes Research and Clinical Practice
  25. The Prevalence and Determinants of Anxiety and Depressive Symptoms in Patients with Type II Diabetes Mellitus in Mogadishu, Somalia: A Cross-Sectional Study
    Nur Adam Mohamed, Rahma Yusuf Haji Mohamud, Fadumo Hussein Hilowle, Yusuf Abdirisak Mohamed, Hawa Nuradin Mohamed · 2024 · Diabetes Metabolic Syndrome and Obesity
  26. Glycemic Variability and Disordered Eating Among Adolescents and Young Adults with Type 1 Diabetes: The Role of Disinhibited Eating
    Tamar Propper‐Lewinsohn, Shlomit Shalitin, Michal Gillon‐Keren, Michal Yackobovitch‐Gavan, Alon Liberman, Moshe Phillip, Roni Elran‐Barak · 2024 · Diabetes Technology & Therapeutics
  27. The Role, Potential Benefits and Cost-effectiveness of Digital Tools for Diabetes Management
    Anders L. Carlson, Sameer Badlani, Viral N. Shah · 2025 · Clinical Therapeutics
  28. The Promising Role of Self-Compassion in Managing Type 1 Diabetes
    CHLOE J. KAELBERER, Molly L. Tanenbaum · 2023 · Endocrines
  29. The Relationship Between Time-Varying Achieved HbA1c and Risk of Coronary Events Depends on Haptoglobin Phenotype Among White and Black ACCORD Participants
    Leah E. Cahill, Rachel A. Warren, Allie S. Carew, Andrew P. Levy, Henry N. Ginsberg, John L. Sapp, Orit Lache, Eric B. Rimm · 2023 · Diabetes Care
  30. Efficacy and safety of insulin glargine 300 units/mL vs insulin degludec in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis
    Eman Alhmoud, Mohamed Omar Saad, Nabil Elhadi Omar · 2024 · Frontiers in Endocrinology
  31. Safety and Efficacy of Using Advanced Hybrid Closed Loop Off-Label in an Infant Diagnosed with Permanent Neonatal Diabetes Mellitus: A Case Report and a Look to the Future
    Federico Pezzotta, Nicola Sarale, Giordano Spacco, Giacomo Tantari, Enrica Bertelli, Giulia Bracciolini, Andrea Secco, Giuseppe d’Annunzio, Mohamad Maghnie, Nicola Minuto et al. · 2024 · Children
  32. Striving for early effective glycaemic and weight management in type 2 diabetes: A narrative review
    ALICE Y.Y. CHENG, Robert J. Heine, Stefano Del Prato, Jennifer B. Green, Vivian Thuyanh Thieu, Meltem Zeytinoglu · 2025 · Diabetes Obesity and Metabolism
  33. Impact of a digital application on HbA1c levels in people with diabetes: a randomized controlled trial
    Lena Roth, Nico Steckhan, Peter E. H. Schwarz · 2025 · Frontiers in Digital Health
  34. Increased Glycemic Variability in Patients With Chronic Pancreatitis and Diabetes Compared to Type 2 Diabetes
    Line Davidsen, Morten Hasselstrøm Jensen, Thomas Kronborg, Stine Hangaard, Peter Vestergaard, Asbjørn Mohr Drewes, Filip Krag Knop, Simon Lebech Cichosz, Søren Schou Olesen · 2025 · Journal of Diabetes Science and Technology
  35. Early insulin degludec with continuous intravenous insulin infusion in the management of diabetic ketoacidosis: A randomized controlled trial
    Kitti Thammakosol, Methus Jantarapootirat, Sirinapa Traiwanatham, Chutintorn Sriphrapradang · 2025 · Diabetes Obesity and Metabolism
  36. Safety, health, and sustainable production of natural sugar substitutes: emerging mechanistic insights
    Yang Wang, Xiang Luo, Cunshan Zhou, Man Zhou, Li Chen, Yabin Feng, Zhenfeng Yang, Xiaojie Yu · 2025 · Food Bioscience
  37. Glycemic Outcomes During Outpatient Use of Automated Insulin Delivery Without Meal Announcement in Adults with Type 1 Diabetes: Results from the CLOSE IT Randomized Controlled Trial
    Tom Wilkinson, Natalie Nanayakkara, David Burren, Alicia Jenkins, Jonathan A. Williman, Celeste Keesing, Erin Boyle, Yasser Elghattis, Alison Bennett, Tim C. Gunn et al. · 2026 · Diabetes Technology & Therapeutics
  38. Association of daytime circadian-aligned activity with glycemic control in type 2 diabetes: Insights from continuous glucose monitoring and wearable data
    Da Young Lee, Jung-Been Lee, Inha Jung, So Jeong Park, Ji Hee Yu, Ji A Seo, Heon-Jeong Lee, Nan Hee Kim · 2026 · Metabolism
  39. Psychometric properties and factor structure of the diabetes eatıng problem survey- revised (DEPS-R) among adults with type 1 diabetes mellitus
    Yasemin Atik Altınok, Beyza Eliuz Tipici, Cemile İdiz, Su Özgür, Ayşe Merve Ok, Kubilay Karşıdağ · 2023 · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity
  40. Intermittent Control for Safe Long-Acting Insulin Intensification for Type 2 Diabetes: In-Silico Experiments *
    Anas El Fathi, Mohammadreza Ganji, Dimitri Boiroux, Henrik L. Bengtsson, Marc D. Breton · 2023 · IEEE Conference on Control Technology and Applications (CCTA)
  41. Estimation of the onset time of diabetic complications in type 2 diabetes patients in Thailand: a survival analysis
    Natthanicha Sauenram, Jutatip Sillabutra, Chukiat Viwatwongkasem, Pratana Satitvipawee · 2023 · Osong Public Health and Research Perspectives
  42. Use of Continuous Glucose Monitoring and Glucagon-Like Peptide 1 Receptor Agonist Therapy to Achieve Individualized Treatment Goals in Insulin-Treated People With Type 2 Diabetes: A Case Series and Expert Opinion
    Nicole M Ehrhardt, Vanita R. Aroda, Rodolfo Javier Galindo, Anne L. Peters, Jay H. Shubrook · 2023 · Clinical Diabetes
  43. Intake of Pistachios as a Nighttime Snack Has Similar Effects on Short- and Longer-Term Glycemic Control Compared with Education to Consume 1–2 Carbohydrate Exchanges in Adults with Prediabetes: A 12-Wk Randomized Crossover Trial
    Terrence M Riley, Penny M. Kris‐Etherton, Tricia L. Hart, Kristina S. Petersen · 2024 · Journal of Nutrition
  44. New Approach to Equitable Intervention Planning to Improve Engagement and Outcomes in a Digital Health Program: Simulation Study
    Jackson A. Killian, Manish Jain, Yugang Jia, Jonathan Amar, Erich S. Huang, Milind Tambe · 2024 · JMIR Diabetes
  45. Impact of breastfeeding on risk of glucose intolerance in early postpartum after gestational diabetes
    Yana Vanlaer, Caro Minschart, Hannah Vrolijk, Paul Van Crombrugge, Carolien Moyson, Johan Verhaeghe, Roland Devlieger, Sofie Vandeginste, Hilde Verlaenen, Chris Vercammen et al. · 2024 · Frontiers in Endocrinology
  46. Risk Stratification, Intention to Fast, and Outcomes of Fasting During Ramadan in People With Diabetes Presenting to a Tertiary Care Hospital
    Suleman Elahi Malik, Shaista Kanwal, Iqbal Haider, Yasir Iqbal, Hammad Naeem, Zabia Jehandad, Javeria Javed, Syeda Adan Shah · 2024 · Endocrine Practice
  47. The Dexcom Community Glucose Monitoring Project: 6-Month Results Using Continuous Glucose Monitoring in Type 2 Diabetes
    Thomas Grace, Andrew Edgington, Laura Reinhart, Timothy Burkart, Elisa Dyer, Jessica Halsey, Karim Baroudi, Christian Hicks, Jennifer E. Layne, Tomas C. Walker · 2024 · Clinical Diabetes
  48. Impact of the COVID-19 Pandemic on Lifestyle Behavior and Clinical Care Pathway Management in Type 2 Diabetes: A Retrospective Cross-Sectional Study
    Giovanni Cangelosi, Stefano Mancin, Paola Pantanetti, Marco Enrico Sguanci, Sara Morales Palomares, Alessia De Luca, Federico Biondini, Francesco Carlo Tartaglia, Gaetano Ferrara, Fabio Petrelli · 2024 · Medicina
  49. The prognostic impact of the Stress Hyperglycemia Ratio on End‐Stage Renal Disease among patients with Diabetic Kidney Disease
    Yutong Zou, Qing Yang, Yanlin Lang, Ke Liu, Jiamin Yuan, Jia Yang, Zhonglin Chai, Mark E. Cooper, Fang Liu · 2024 · Diabetes Obesity and Metabolism
  50. Pasireotide-induced hyperglycemia in Cushing’s disease and Acromegaly: A clinical perspective and algorithms proposal
    Przemysław Witek, Marek Bolanowski, Adam Jacek Kretowski, Aleksandra Głowińska · 2024 · Frontiers in Endocrinology
  51. Postprandial Glucose Response in Type 2 Diabetes Mellitus Patients and Possible Antioxidant Properties of a Plant-Based Snack Bar
    Maria Dimopoulou, Αlexandra Bargiota, Eleftheria Barmpa, Zozo Outskouni, Dimitrios Stagos, Varvara Trachana, Odysseas Androutsos, Olga Gortzi · 2024 · Foods
  52. Screening and management of hospital hyperglycemia in non-critical patients: a position statement from the Brazilian Diabetes Society (SBD)
    Emerson Cestari Marino, Denise Momesso, Marcos Tadashi Kakitani Toyoshima, Maria Fernanda Ozorio de Almeida, Beatriz D'Agord Schaan, Leandra Anália Freitas Negretto, Augusto Cezar Santomauro Junior, Priscilla Cukier, Paulo Genestreti, Alina Coutinho Rodrigues Feitosa et al. · 2025 · Diabetology & Metabolic Syndrome
  53. Predict and prevent microvascular complications of type 2 diabetes: a cross-sectional and longitudinal study in Chinese communities
    Zhaoxiang Liu, Lianhao Zhou, Wenhui Zhao, Lixia Jin, Jinping Zhang, Yajing Zhang, Yufeng Li, Guixia Deng, HE Ji-quan, Xinghua Zhao et al. · 2025 · Frontiers in Endocrinology
  54. Relative Hyperglycemia and In-Hospital Bleeding Across Glycemic Status in Patients on High-Intensity Antithrombotic Therapy
    Chong Zhang, Junxiang Liu, Wennan Liu, Hangkuan Liu, Pengfei Sun, Yiwen Fang, Jingbo Yang, Haonan Sun, Yongle Li, Roger Foo et al. · 2025 · Circulation Journal
  55. Sex-specific and metabolic subgroup heterogeneity in high-density lipoprotein cholesterol associations with diabetic kidney disease risk: a retrospective cohort study
    Huabin Wang, Xuanlin Jin, Fenfang Lin, Guangming Chen, Meili Lin, Yongjun Ma · 2025 · Lipids in Health and Disease
  56. Prevalence and characteristics of obesity in patients with type-2 diabetes mellitus in primary care centers in Bahrain: A cross-sectional study
    Mahmood Alawainati, Zahra A. Ayoob, Aala A. AlQari, Fatema Makhlooq, Huda S. Naser, Fajer Bukamal · 2023 · Journal of Family and Community Medicine
  57. National Trends in Glucagon Prescriptions Among U.S. Adults With Diabetes and End-Stage Kidney Disease Treated by Dialysis: 2013–2017
    Rodolfo Javier Galindo, Shealeigh A. Inselman, Guillermo E. Umpierrez, Bobak Moazzami, Jair Munoz Mendoza, Mohammed Kumail Ali, Katherine R. Tuttle, Rozalina G. McCoy · 2023 · Diabetes Care
  58. Clinical and Lifestyle Determinants of Continuous Glucose Monitoring Metrics in Insulin-Treated Patients with Type 2 Diabetes Mellitus
    Won‐Young Lee, Nam‐Ho Kim, Inha Jung, So Young Park, Ji Hee Yu, Ji A Seo, Jihee Kim, Kyeong Jin Kim, Nam Hoon Kim, Hye Jin Yoo et al. · 2023 · Diabetes & Metabolism Journal
  59. Glycaemic Control and Weight Reduction: A Narrative Review of New Therapies for Type 2 Diabetes
    Luis Alberto Vázquez, Irene Romera, Miriam Rubio‐de Santos, Javier Escalada · 2023 · Diabetes Therapy
  60. Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease and Diabetes Mellitus: A Subgroup Analysis of the ADAPTABLE Trial
    Dennis I. Narcisse, Hwasoon Kim, Lisa Miller Wruck, Amanda Stebbins, Daniel Muñoz, Sunil B. Kripalani, Mark B. Effron, Kamal Gupta, R. David Anderson, Sandeep K Jain et al. · 2023 · Diabetes Care
  61. The Impact of Metabolic Memory on Immune Profile in Young Patients with Uncomplicated Type 1 Diabetes
    Jolanta Neubauer‐Geryk, Melanie Wielicka, Małgorzata Myśliwiec, Katarzyna Zorena, Leszek Bieniaszewski · 2024 · International Journal of Molecular Sciences
  62. Chronic kidney disease progression in diabetic patients: Real world data in general practice
    Michelangelo Rottura, Selene Francesca Anna Drago, Viviana Maria Gianguzzo, Antonino Molonia, Giovanni Pallio, Riccardo Scoglio, Sebastiano Marino, Angela Alibrandi, Egidio Imbalzano, Francesco Squadrito et al. · 2024 · Heliyon
  63. The Beneficial Effect of Glycemic Control against Adverse Outcomes in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease
    Dong‐Hwa Lee · 2023 · Diabetes & Metabolism Journal
  64. Prevalence, patterns, and determinants of vascular complications of type 2 diabetes in a teaching hospital in Addis Ababa, Ethiopia: a retrospective study
    Solela, Gashaw, Gessesse, Henok A., Zegeye, Hailu, Worku, Amare, Leulseged, Beza · 2024 · BMC Endocrine Disorders
  65. Cost Analysis of the FreeStyle Libre Systems in People with Type 2 Diabetes Mellitus on Basal Insulin with Poor Glycemic Control: A Spanish Perspective
    Francisco Javier Ampudia‐Blasco, Alberto de la Cuadra-Grande, Virginia Bellido, Ana María Cebrián Cuenca, Pedro Mezquita‐Raya, Juana Carretero‐Gómez, Antonio-Miguel Hernández Martínez, Itziar Oyagüez, Fernando Gómez Peralta · 2025 · Diabetes Technology & Therapeutics
  66. Synergistic effects of diabetes and sarcopenic obesity on cardiovascular disease risk in middle-aged and elderly Chinese adults: a large-scale prospective cohort study
    Fang Wan, Ruonan Lian, Jing Huang, DU Jian-ling · 2025 · Aging Clinical and Experimental Research
  67. An mHealth Text Messaging Program Providing Symptom Detection Training and Psychoeducation to Improve Hypoglycemia Self-Management: Intervention Development Study
    Yu Kuei Lin, James E. Aikens, Nicole de Zoysa, Diana Hall, Martha M. Funnell, Robin B Nwankwo, K Kloss, Melissa J. DeJonckheere, Rodica Pop‐Busui, Gretchen Piatt et al. · 2023 · JMIR Formative Research
  68. Advances in diabetes management: have pregnancy outcomes in women with type 1 diabetes changed in the last decades?
    Fabrizia Citro, Cristina Bianchi, Francesca Nicolì, Michele Aragona, Piero Marchetti, Graziano Di Cianni, Alessandra Bertolotto · 2023 · Diabetes Research and Clinical Practice
  69. Diabetes Mellitus and Poor Glycemic Control Are Associated With a Higher Risk of Lumbar Spinal Stenosis
    Shai S. Shemesh, Asaf Laks, Itzik Cohen, ‪Adi Turjeman‬‏, Ronen Blecher, Assaf Kadar · 2023 · Spine
  70. Effects of intensive glycemic control on microvascular outcomes in type 2 diabetes mellitus are modified by long-term HbA1c variability: A post hoc analysis of the ACCORD trial
    Jia-Min Wang, Meng-Yuan Miao, Yiping Jia, Xiaowen Wang, Xianbo Wu, Zhongxiao Wan, Yan Zheng, Li‐Qiang Qin, Fu‐Rong Li, Guo‐Chong Chen · 2024 · Diabetes Research and Clinical Practice
  71. Diabetes, hemoglobin A1c, and cognitive performance in older adults: is there any impact of frailty? Evidence from the ELSI-Brazil study
    Jonas Gordilho Souza, Daniela Souza Farias‐Itao, Márlon Juliano Romero Aliberti, Tiago da Silva Alexandre, Cláudia Szlejf, Cleusa P. Ferri, Maria Fernanda Lima‐Costa, Cláudia Kimie Suemoto · 2024 · Brazilian Journal of Medical and Biological Research
  72. HbA1c overestimates the glucose management indicator: a pilot study in patients with diabetes, chronic kidney disease not on dialysis, and anemia using isCGM
    Ana María Gómez Medina, Camilo Alberto González, Óscar Múñoz, Yalinne Gómez-Quesada, Pablo Jaramillo, Diana Cristina Henao, Luis M. Rodríguez, Yurany Molina · 2024 · Therapeutic Advances in Endocrinology and Metabolism
  73. Conceptualizing Treatment Burden among People with Type 2 Diabetes
    Leandra Bitterfeld, Sean M. Reed · 2024 · Nursing Forum
  74. Assessment of myocardial microvascular dysfunction in patients with different stages of diabetes mellitus: An adenosine stress perfusion cardiac magnetic resonance study
    Xinni Li, Sang Soo Kang, Zhigang Lu, Yuting Liu, Danzengquyang, Huoyuan Xiao, Wenkun Ma, Jingwei Pan · 2024 · European Journal of Radiology
  75. Enhancing Type 2 Diabetes Treatment Decisions With Interpretable Machine Learning Models for Predicting Hemoglobin A1c Changes: Machine Learning Model Development
    Hisashi Kurasawa, Kayo Waki, Tomohisa Seki, Akihiro Chiba, Akinori Fujino, Katsuyoshi Hayashi, Eri Nakahara, Tsuneyuki Haga, Takashi Noguchi, Kazuhiko Ohe · 2024 · JMIR AI
  76. Glycaemic and weight effects of metabolic surgery or semaglutide in diabetes dosage for patients with type 2 diabetes
    Erik Stenberg, Yang Cao, Johan Ottosson, Suzanne Hedberg, Erik B. Näslund · 2024 · Diabetes Obesity and Metabolism
  77. Impact of community public health care on treatment effect, health cognition, and self-management in patients with type 2 diabetes
    Hong Shi, Chun Liu, Hongyan Luo · 2024 · World Journal of Clinical Cases
  78. Dulce Digital-Me: results of a randomized comparative trial of static versus adaptive digital interventions for Latine adults with diabetes
    Athena Philis‐Tsimikas, Addie L. Fortmann, Taylor L. Clark, Samantha R. Spierling Bagsic, Emilia Farcas, Scott C. Roesch, JAMES H. SCHULTZ, Todd Gilmer, Job Godino, Kimberly L. Savin et al. · 2024 · Annals of Behavioral Medicine
  79. Switching From Open-source to Commercial Advanced Automated Insulin Delivery System: Glucose Management and Patient Perspective in an Adult Living With Type 1 Diabetes
    Maha Lebbar, Anne Bonhoure, RÉMI P.R. RABASA-LHORET, Zekai Wu · 2024 · Canadian Journal of Diabetes
  80. Correlation between key indicators of continuous glucose monitoring and the risk of diabetic foot
    Xinqian Geng, Shun-Fang Chen, Fei-Ying Wang, Huijun Yang, Yunli Zhao, Zhangrong Xu, Ying Yang · 2025 · World Journal of Diabetes
  81. Assessing non‐adjunctive CGM safety at home and in new markets (ANSHIN)
    Christy Chao, Sarah B. Andrade, Simon Bergford, Peter M. Calhoun, John B. Welsh, Tomas C. Walker, ANSHIN Study Group · 2023 · Endocrinology Diabetes & Metabolism
  82. Association between effect of acceptance of illness and medication adherence, metabolic control, and risk of diabetic foot in individuals with diabetes
    Derya Akça Doğan, Hülya Ek, Semure Zengi, Seda Pehlivan, Canan Ersoy · 2023 · Primary care diabetes
  83. Anti–Plexin-D1 Seropositive Small Fiber Neuropathy: Clinical Phenotype, Demographics, and Literature Review
    Peyton J. Murin, Ivana Massabki, Jafar Kafaie · 2024 · Journal of Clinical Neuromuscular Disease
  84. Factors influencing optimal diabetes care and clinical outcomes in Thai patients with type 2 diabetes mellitus: a multilevel modelling analysis
    Apinya Surawit, Tanyaporn Pongkunakorn, Thamonwan Manosan, Pichanun Mongkolsucharitkul, Parinya Chamnan, Krishna Suvarnabhumi, Thanapat Puangpet, Sophida Suta, Sureeporn Pumeiam, Bonggochpass Pinsawas et al. · 2024 · BMJ Open
  85. “Obviously, Nothing's Gonna Happen in Five Minutes”: How Adolescents and Young Adults Infrastructure Resources to Learn Type 1 Diabetes Management
    Tian Xu, Emily Jost, Laurel H. Messer, Paul F. Cook, Gregory P. Forlenza, Sriram Sankaranarayanan, Casey L. Fiesler, Stephen Voida · 2024 · CHI Conference on Human Factors in Computing Systems
  86. EValuating Glucose ContrOL Using a Next-GeneraTION Automated Insulin Delivery Algorithm in Patients with Type 1 and Type 2 Diabetes: The EVOLUTION Study
    Tom Wilkinson, Renee A. Meier, Niranjala M. Hewapathirana, Claire S. Lever, Solita Donnelly, Rachael Sampson, Jonathan A. Williman, Mert Sevil, Saeed Salavati, SAM P. CARL et al. · 2025 · Diabetes Technology & Therapeutics
  87. Prevalence and Determinants of Suboptimal Glycemic Control in Type 2 Diabetes Mellitus Patients in Primary Health Care
    Enas H. Alfalogy, Rasha T. Almatrafi, Khalid Al-shahrani, Nahla H. Hariri · 2025 · The Open Public Health Journal
  88. Impact of Flash Glucose Monitoring on the Fear of Hypoglycemia Phenomenon in Adults with Type 1 Diabetes
    Pablo Rodríguez de Vera Gómez, Carmen Mateo Rodríguez, Beatriz Rodríguez Jiménez, Lucía Hidalgo Sotelo, Mercedes Peinado Ruiz, Eduardo Torrecillas del Castillo, Desireé Ruiz-Aranda, Isabel Serrano Olmedo, Ángela Candau Martín, Maria Asunción Martínez‐Brocca · 2024 · Diabetes Technology & Therapeutics
  89. Dietary composition and time in range in population with type 2 diabetes mellitus-exploring the association using continuous glucose monitoring device
    Aditi Deshmane, Arti Muley · 2024 · Endocrine
  90. Two years with GIOIA ‘Effects of gliflozins and gliptins on markers of cardiovascular damage in type 2 diabetes’: A prospective, multicentre, quasi‐experimental study on sodium‐glucose cotransporter 2 and dipeptidyl peptidase‐4 inhibitors in diabetes clinical practice
    Miriam Longo, Paola Caruso, Lorenzo Scappaticcio, Maria Ida Maiorino, Giuseppe Bellastella, Annalisa Capuano, Katherine Esposito, Dario Giugliano · 2024 · Diabetes Obesity and Metabolism
  91. Effects of an Electronic Medical Records-Linked Diabetes Self-Management System on Treatment Targets in Real Clinical Practice: Retrospective, Observational Cohort Study
    So Jung Yang, Sun‐Young Lim, Yoon‐Hee Choi, Jin‐Hee Lee, Kun‐Ho Yoon · 2024 · Endocrinology and Metabolism
  92. Diabetes remission in newly diagnosed type 2 diabetes mellitus through short‐term continuous subcutaneous insulin infusion intensive therapy combined with low‐carbohydrate diet treatment
    Xuemei Huang, Jiajin Jiang, Li Liu, Yuanyuan Lin, Feng Zhang, Xiaoshan Ling, Haitao Wei, Guangjing Huang, Jinqun Ye, Cen Huang et al. · 2024 · Journal of Diabetes Investigation
  93. OptimAAPP , a smartphone insulin dose calculator for carbohydrate, fat, and protein: A cross‐over, randomised controlled trial in adolescents and adults with type 1 diabetes using multiple daily injection therapy
    Tenele A. Smith, Nisha Venkatesh, KERRYN L. ROEM, Jean Lu, Emma Netzer, Adrian M. Medioli, Stuart Szwec, David Norman O'Neal, Bruce R. King, Carmel E. Smart · 2024 · Diabetic Medicine
  94. Composite cardiovascular risk factor control in US adults with diabetes and relation to social determinants of health: The All of Us research program
    Frances Golden, Johnathan Tran, Nathan D. Wong · 2025 · American Journal of Preventive Cardiology
  95. Non-invasive blood glucose level monitoring using antennas: a comprehensive review report
    Nidhi Upadhyay, Amanpreet Kaur, Arnab Pattanayak, Ashima Singh · 2025 · Discover Electronics
  96. Continuous Glucose Monitoring Systems Can Meet the Challenge of Glucose Management and Beyond in Individuals with Type 2 Diabetes: An Expert Multidisciplinary Position
    Małgorzata Myśliwiec, Leszek Czupryniak, Ryszard Gellert, Piotr Jankowski, Agnieszka Mastalerz–Migas, Marek Rękas, Krzysztof Strojek, Mieczysław Walczak · 2025 · Diabetes Therapy
  97. Counseling Preferences Among Patients With Type 2 Diabetes: Implications for Personalized Care
    Thao Ngoc Phuong Nguyen, Chi Nguyen Thi, Trang Pham Thi Phuong, Quy Nguyen Ngoc, Hong Tham Pham · 2025 · Journal of Diabetes Research
  98. Usability of Continuous Glucose Monitoring for Older Adults with Type 2 Diabetes: A Systematic Review
    April Savoy, Cristina Barboi, Melissa R Thomas, Michael Weiner · 2025 · Diabetes Technology & Therapeutics
  99. Prognostic value of glycaemic variability for mortality in cardiogenic shock patients: a retrospective cohort study
    Linfeng Xie, Suxin Luo · 2025 · Cardiovascular Diabetology
  100. Cost–Utility Analysis of FreeStyle Libre Systems in People with Type 2 Diabetes Mellitus on Treatment with Basal Insulin and Poor Glycemic Control in Spain
    Mireya Robles-Plaza, Fernando Gómez Peralta, Virginia Bellido, Francisco Javier Ampudia‐Blasco, Juana Carretero‐Gómez, Ana María Cebrián Cuenca, Alberto de la Cuadra-Grande, Pedro Mezquita‐Raya · 2025 · Diabetes Therapy